Cargando…

Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience

INTRODUCTION: Basal insulin (BI) infusion in pump therapy of type 1 diabetes (T1DM) mimics physiological secretion during the night and between meals. The recommended percentage of the total BI to daily insulin dose (termed the %BI) ranges between 30 and 50%. We analyzed whether this recommendation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matejko, Bartłomiej, Kukułka, Aneta, Kieć-Wilk, Beata, Stąpór, Agnieszka, Klupa, Tomasz, Malecki, Maciej T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008663/ https://www.ncbi.nlm.nih.gov/pubmed/29974056 http://dx.doi.org/10.1155/2018/1473160

Ejemplares similares

Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps?
por: Matejko, Bartlomiej, et al.
Publicado: (2015)

Predictors of the maximal oxygen consumption in adult patients with type 1 diabetes treated with personal insulin pumps
por: Matejko, Bartłomiej, et al.
Publicado: (2021)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

Insulin pump settings and glucose patterns during a 1008-km non-stop bicycle race in a patient with type 1 diabetes mellitus
por: Klupa, Tomasz, et al.
Publicado: (2018)

The Gut Microbiota Profile According to Glycemic Control in Type 1 Diabetes Patients Treated with Personal Insulin Pumps
por: Mrozinska, Sandra, et al.
Publicado: (2021)

The Impact of a Pure Protein Load on the Glucose Levels in Type 1 Diabetes Patients Treated with Insulin Pumps
por: Klupa, Tomasz, et al.
Publicado: (2015)

Assessment of Newly Proposed Clinical Criteria to Identify HNF1A MODY in Patients with an Initial Diagnosis of Type 1 or Type 2 Diabetes Mellitus
por: Grzanka, Malgorzata, et al.
Publicado: (2016)

Assessment of selected muscle damage markers and zonulin concentration after maximum-intensity exercise in men with type 1 diabetes treated with a personal insulin pump
por: Matejko, Bartłomiej, et al.
Publicado: (2023)

Quality of life in the course of a one-year use of an advanced hybrid closed-loop system in adults with type 1 diabetes previously naïve to advanced diabetes technology
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
por: Szopa, Magdalena, et al.
Publicado: (2015)

Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized, Controlled Study
por: Matejko, Bartłomiej, et al.
Publicado: (2022)

Psychological Crisis Intervention for COVID-19 Lockdown Stress in Patients With Type 1 Diabetes Mellitus: Survey Study and Qualitative Analysis
por: Cyranka, Katarzyna, et al.
Publicado: (2021)

Changes in Oxidative and Nitrosative Stress Indicators and Vascular Endothelial Growth Factor After Maximum-Intensity Exercise Assessing Aerobic Capacity in Males With Type 1 Diabetes Mellitus
por: Tota, Łukasz, et al.
Publicado: (2021)

Evaluation of Psychological Resources of Young Adults With Type 1 Diabetes Mellitus During the Transition From Pediatric to Adult Diabetes Clinics: Multicenter Cross-sectional Study
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

Metabolic control in type 1 diabetes patients practicing combat sports: at least two-year follow-up study
por: Benbenek-Klupa, Teresa, et al.
Publicado: (2015)

Physiological Characteristics of Type 1 Diabetes Patients during High Mountain Trekking
por: Matejko, Bartłomiej, et al.
Publicado: (2020)

Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
por: Boucher-Berry, Claudia, et al.
Publicado: (2016)

Depression and quality of sleep in patients with type 1 diabetes being under regular diabetes care
por: Cyranka, K., et al.
Publicado: (2023)

Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment
por: Surowiec, Paulina, et al.
Publicado: (2021)

Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump
por: Kuroda, Akio, et al.
Publicado: (2011)

Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus
por: Mrozinska, Sandra, et al.
Publicado: (2016)

Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance
por: Razny, Urszula, et al.
Publicado: (2011)

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
por: Holterhus, Paul-Martin, et al.
Publicado: (2013)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM
por: Hohendorff, Jerzy, et al.
Publicado: (2022)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus
por: Laimer, Markus, et al.
Publicado: (2016)

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus
por: Hohendorff, J., et al.
Publicado: (2017)

Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
por: Rys, Przemyslaw, et al.
Publicado: (2015)

Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods
por: Chow, Nelson, et al.
Publicado: (2016)

Diabetes Management Delivery and Pregnancy Outcomes in Women with Gestational Diabetes Mellitus during the First Wave of the 2020 COVID-19 Pandemic: A Single-Reference Center Report
por: Wilk, Magdalena, et al.
Publicado: (2021)

Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
por: Freckmann, Guido, et al.
Publicado: (2019)

“Fighting spirit”: specific personality traits as one of the key factors for sport championship in type 1 diabetes mellitus
por: Cyranka, Katarzyna, et al.
Publicado: (2021)

Insulin pump therapy in transient neonatal diabetes mellitus
por: Park, Joong Heum, et al.
Publicado: (2013)

Diet-Related Knowledge and Physical Activity in a Large Cohort of Insulin-Treated Type 2 Diabetes Patients: PROGENS ARENA Study
por: Klupa, Tomasz, et al.
Publicado: (2016)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
por: Nasrallah, Sami N., et al.
Publicado: (2012)

The relationship between different C-peptide level and insulin dose of insulin pump
por: Wei, Yihan, et al.
Publicado: (2021)

Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study
por: Kania, Michał, et al.
Publicado: (2023)

Oral Microbiota—One Habitat or Diverse Niches? A Pilot Study of Sampling and Identification of Oral Bacterial and Fungal Biota in Patients with Type I Diabetes Mellitus Treated with Insulin Pump
por: Gregorczyk-Maga, Iwona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v12908nrjmqiq4vt8e132thu4p